a public good project by the
Synthesis
Company
of California

© 2026

L. Zhang | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

L. Zhang

Novartis (United States)(US)

Research Areas

Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune and Inflammatory Disorders Research

Most-Cited Works

→ Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52‐week results from a Phase 3 double‐blind randomized, controlled trial(2020)93 cited